Tonix Pharmaceuticals Holding (TNXP) Cash & Current Investments (2023 - 2025)
Historic Cash & Current Investments for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $190.1 million.
- Tonix Pharmaceuticals Holding's Cash & Current Investments rose 57316.62% to $190.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $190.1 million, marking a year-over-year increase of 57316.62%. This contributed to the annual value of $98.8 million for FY2024, which is 29592.75% up from last year.
- Latest data reveals that Tonix Pharmaceuticals Holding reported Cash & Current Investments of $190.1 million as of Q3 2025, which was up 57316.62% from $125.3 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Cash & Current Investments registered a high of $190.1 million during Q3 2025, and its lowest value of $4.2 million during Q2 2024.
- Its 3-year average for Cash & Current Investments is $65.0 million, with a median of $28.2 million in 2024.
- In the last 5 years, Tonix Pharmaceuticals Holding's Cash & Current Investments plummeted by 9020.63% in 2024 and then skyrocketed by 291566.41% in 2025.
- Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Cash & Current Investments stood at $24.9 million in 2023, then skyrocketed by 295.93% to $98.8 million in 2024, then surged by 92.41% to $190.1 million in 2025.
- Its Cash & Current Investments stands at $190.1 million for Q3 2025, versus $125.3 million for Q2 2025 and $131.7 million for Q1 2025.